The residential real estate market faced significant turbulence in January, registering a decline in home sales linked directly to high mortgage rates and persistent elevated home prices. Data indicates that pending sales, which reflect signed contracts on existing homes, fell by 4.6% from December 2023. This drop marked a troubling trend, as it represented the
0 Comments
In recent years, the push for increased energy efficiency has been a focal point for both environmental advocates and policymakers. A significant step was the passage of the Inflation Reduction Act in 2022, which allocated a whopping $8.8 billion in federal funds aimed at helping consumers retrofit their homes for improved energy efficiency. The program
0 Comments
In recent news, the Social Security Administration (SSA) has introduced a revised timeline for the distribution of a one-time retroactive payment and subsequent benefit increases under the newly enacted Social Security Fairness Act. This law, which was signed by President Joe Biden on January 5, addresses two longstanding provisions—the Windfall Elimination Provision (WEP) and the
0 Comments
Recent reports indicate a notable decline in mortgage interest rates, reaching their lowest point in two months. This shift, however, has not spurred an anticipated increase in consumer demand for mortgages. The Mortgage Bankers Association has reported a 1.2% decrease in total mortgage application volume over the previous week, reflecting a complex and potentially stagnant
0 Comments
Recent findings from Charles Schwab’s quarterly client survey reveal a notable surge in bullish sentiment among traders, indicating that optimism persists even in a stock market deemed expensive by many. The survey, which included responses from 1,040 active participants last month, showed that 51% of traders identify as bullish, surpassing the bearish contingent at 34%.
0 Comments
Eli Lilly has taken a significant step towards enhancing the accessibility of its weight-loss drug, Zepbound, particularly for individuals without insurance coverage. The recent announcement of higher doses available in more affordable single-dose vials reflects the company’s commitment to reaching a broader audience amidst surging demand. This initiative not only addresses the rising need for
0 Comments